ProMIS Neurosciences, Inc.

NASDAQ:PMN

Biotechnology

Healthcare
$11.08 -0.14%

-$0.02 today

Market cap
$99.36M
Beta
-0.22
P/E (TTM)
-0.6
EPS (TTM)
-$4.62
52W Low $6.27High $27.40

Volume 0.13M

Average 0.07M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$40.17M

FY 2025 · Annual

Net Income

-$39.72M

FY 2025 · Annual

Income Statement

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Revenue16.68K0000
Cost of Revenue5.85M010.44M00
Gross Profit(5.84M)0(10.44M)00
Gross Margin-35031.9%————
Research & Development4.95M16.09B7.88M10.64M33.38M
Selling, General & Admin3.31M7.29B6.38M6.19M6.79M
Operating Expenses4.63M23.38B8.45M16.83M40.17M
Depreciation & Amortization45.83K028.04K00
EBITDA(9.33M)(17.78B)(17.81M)2.86M(39.72M)
EBITDA Margin-55923.2%————
Operating Income(10.57M)(23.38B)(18.9M)(16.83M)(40.17M)
Operating Margin-63350.5%————
Interest Income4.73K0000
Interest Expense416.29K282.06M201.39K76.78K0
Other Income / Expenses(1.91M)5.32B1.39M19.61M448.16K
Income Before Tax(12.48M)(18.06B)(17.51M)2.78M(39.72M)
Pre-Tax Margin-74804.2%————
Income Tax Expense00000
Net Income(11.98M)(18.06B)(17.51M)2.78M(39.72M)
Net Margin-71819.3%————
EPS (Basic)(51.77)(60.25)(35.50)2.75(22.61)
EPS (Diluted)(51.77)(60.25)(35.50)2.75(22.61)
Weighted Avg Shares231.42K300.1K491.71K1.04M1.76M
Weighted Avg Shares (Diluted)231.43K300.1K491.71K1.06M1.76M

PMN Earnings Waterfall · TTM

NASDAQ:PMN · Revenue to Net Income

Key Ratios

EPS$-16.89
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$42.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-16.89, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 6, 2026
3Initial statement of beneficial ownershipOct 6, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 13, 2026
8-KCurrent reportAug 13, 2026

How much revenue does PMN generate?

ProMIS Neurosciences, Inc. (PMN) reported $0.00 of revenue in fiscal 2025.

Is PMN profitable?

ProMIS Neurosciences, Inc. (PMN) reported -$39.72M of net income.